tiprankstipranks
Trending News
More News >

Calliditas Therapeutics presents data at European Renal Association Congress

Calliditas Therapeutics announced the presentations of an additional efficacy analysis of Nefecon and a real-world analysis of the use of systemic glucocorticoids – SGC – in IgA nephropathy. The presented efficacy analysis of Nefecon and sparsentan showed that treatment with Nefecon for 9 months was associated with estimated glomerular filtration rate benefit compared with continuous treatment with sparsentan. Additionally, the findings of a real-world analysis of challenges associated with the use of systemic glucocorticoids demonstrate significant side effects and costs for IgAN patients treated with systemic glucocorticoids, such as Prednisone and Prednisolone.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue